Double-blind, randomized trial found it did not reduce hospitalizations even if taken early
(Newser) -
Treating COVID-19 patients with ivermectin did not alleviate the illness or reduce hospitalizations, according to a major double-blind, randomized clinical trial published Wednesday, which effectively rules out the anti-parasitic drug as a treatment. "There's really no sign of any benefit," Dr. David Boulware, an infectious-disease expert at...